
‘Olmi' season ends with low sales and uncertain future for vendors
Panaji:
The monsoon in Goa brings with it the much-anticipated olmi, the rare and prized wild mushroom that grows under termite mounds in the state's forested areas. For generations, this earthy delicacy has supported livelihoods, especially for rural women who harvest and sell it.
But this year, the joy soured.
As the season drew to an early close, vendors from Banastarim and Canacona, who sell this edible fungi in Panaji, grappled with a sharp decline in sales. This season saw a steep spike in prices, starting at Rs 700 per portion (approximately 50 mushrooms), pricing out many regular buyers.
'Earlier, office-goers, lawyers, and residents would flock to us and buy two or three portions without bargaining much,' said Taramuti Kunkolkar, a veteran mushroom seller from Banastarim.
'But this year, customers just walk by. Even after reducing prices to Rs 550 or Rs 600, they still don't buy. We have to return home with nearly 50% of the mushrooms in tow.'
Olmi's rarity and foraging process have always commanded a higher price tag, but inflation and shrinking incomes have made it less accessible. However, the price was only part of the problem. The real shock came with the shifting of the District and Sessions Court from its historic location in the heart of Panaji to the suburban locality of Merces.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Libas Purple Days Sale
Libas
Undo
For decades, the sidewalk outside the Panaji court was an unofficial but thriving marketplace for seasonal goods. Mushroom vendors — mostly elderly women from Banastarim, Sattari, and Ponda — counted on the steady flow of litigants, lawyers, and passers-by.
'The court moving to Merces has destroyed our business,' said Lila Kankonkar, another vendor.
Adding to the sellers' troubles is an emerging conservation narrative. As awareness grows about the ecological importance of wild mushrooms, particularly their role in maintaining soil health and forest biodiversity, voices advocating for responsible foraging and conservation have grown louder.
Earlier this month, the Goa State Biodiversity Board (GSBB) warned against the overexploitation of these edible mushrooms, appealing not to encourage the sale and consumption.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
24 minutes ago
- Economic Times
Regaal Resources raises Rs 92 crore from anchor investors ahead of IPO
Regaal Resources raised ₹92 crore from anchor investors before its ₹306 crore IPO, opening Tuesday. The Bihar-based maize products maker allotted shares to domestic and overseas institutions at ₹102 each. Listing is set for August 20. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Regaal Resources has mobilised Rs 92 crore from anchor investors ahead of its IPO, which opens for public subscription on Tuesday. The Kolkata-based maize-based specialty products manufacturer informed the exchanges on Monday that it allotted 89,99,856 equity shares at Rs 102 apiece, including a share premium of Rs 97, to a clutch of institutional anchor book saw participation from a diverse mix of domestic and overseas institutions, including Taurus Mutual Fund, Meru Investment Fund, Authum Investment and Infrastructure, Universal Sompo General Insurance, Zeta Global Funds (OEIC) PCC, and several domestic alternative investment funds (AIFs).Regaal Resources operates from Kishanganj, Bihar, one of India's top three maize-growing states, and is among the country's top 10 maize milling companies by capacity, with an installed crushing capacity of 750 tonnes per portfolio includes native maize starch, modified starch, co-products such as gluten, and value-added products like maize flour, icing sugar, and baking Rs 306 crore IPO comprises a fresh issue and an offer for sale, with a price band set at Rs 96–102 per can bid for a minimum lot of 144 shares. Of the total issue, up to 50% is reserved for qualified institutional buyers (QIBs), 35% for retail investors, and 15% for non-institutional investors (NIIs).The subscription window will close on Thursday. Tentative allotment is scheduled for August 18, with refunds and credit of shares to demat accounts on August 19. The stock is expected to list on both BSE and NSE on August 20. Pantomath Capital Advisors and Sumedha Fiscal Services are acting as the book-running lead managers to the issue.
&w=3840&q=100)

Business Standard
24 minutes ago
- Business Standard
IHCL to buy stake in firms operating The Clarks Hotels & Resorts' brand
Tata Group-owned Indian Hotels Company Ltd (IHCL) on Monday said a committee constituted by its board has approved and executed agreements to acquire about 51 per cent stake each in two entities -- ANK Hotels and Pride Hospitality -- which have a portfolio of 135 hotels operated under 'The Clarks Hotels & Resorts' brand. The transactions to be executed via cash consideration are expected to be completed by November 15, 2025. The share subscription and purchase agreements and shareholders' agreements were executed to acquire about 51 per cent equity stake for an amount not exceeding Rs 110 crore in ANK Hotels Pvt Ltd, and Rs 94 crore in Pride Hospitality Pvt Ltd, according to a regulatory filing. "The foregoing companies have a portfolio of 135 hotels which are operated under 'The Clarks Hotels & Resorts', primarily across India, IHCL said. The country's biggest hospitality player has also signed a distribution & marketing agreement with 'Brij Hospitality Pvt Ltd', which has a portfolio of 19 hotels under the Brij Brand, primarily across the country. The transactions (subject to fulfilment of certain condition precedents) aim to address India's heterogenous market landscape and provide deeper geographical penetration across India in the midscale segment while continuing to pursue its asset light growth strategy, IHCL stated in the filing. The proposed acquisition of 51 per cent stake in ANK Hotels Pvt Ltd will add a portfolio of 111 midscale hotels (with 67 hotels in operation) to IHCL's portfolio. Established in 1996, ANK Hotels Pvt Ltd has its registered office in Lucknow. It has presence in India & Sri Lanka. Pride Hospitality Pvt Ltd, established in 2005, has its registered office in Jaipur. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
&w=3840&q=100)

Business Standard
24 minutes ago
- Business Standard
GIC, TPG-backed AHH targets 20 AINU hospitals by FY30, eyes GI entry
Asian Healthcare Holdings (AHH), backed by Singapore sovereign wealth fund GIC and private equity firm TPG, plans to expand to about 20 nephrology and urology facilities under its Asian Institute of Nephrology and Urology (AINU) brand by the end of FY30. AINU currently operates over 500 beds in seven hospitals across Hyderabad, Visakhapatnam, Siliguri, and Chennai. It inaugurated a 200-bed flagship hospital in Hyderabad on Monday. 'Between FY26 and FY27, there will be another three to four hospitals, which will take our tally to 12-13 facilities,' Vishal Bali, executive chairman of AHH, told Business Standard. With this expansion, AINU's bed capacity will reach about 850. He added that the next phase of growth will focus on tier-II cities such as Bhubaneswar, Patna, Coimbatore, and Pune. Sandeep Guduru, chief executive officer of AINU, said Rs 150 crore in capital expenditure has been earmarked to open three to four new urology and nephrology facilities in the next 12 months. 'We are also expanding our robotic surgery capabilities in a couple of our other cities,' he added. Bali said that between FY27 and FY30, AINU could add another seven to eight hospitals, taking the total to around 20. AHH, which owns Motherhood Hospitals (maternity care), AINU, and Nova IVF (IVF), is a healthcare platform specialising in single-specialty hospitals. The network now plans to enter one or two additional specialties. 'Gastroenterology (GI) is one such specialty that we would be keen to explore,' Bali said. He explained that GI offers a strong outpatient department with endoscopy, as well as inpatient procedures largely driven by minimal access surgery. On the possibility of an initial public offering, Bali declined to share a timeline, saying it was a matter of when the investors deemed it appropriate. 'However, with the Ebitda that we have on the platform today, the company could potentially go to an IPO even in the next 16 or 18 months,' he said.